Lincocin

국가: 뉴질랜드

언어: 영어

출처: Medsafe (Medicines Safety Authority)

유효 성분:

Lincomycin hydrochloride monohydrate 340.26 mg/mL equivalent to lincomycin 300 mg/mL

제공처:

Pfizer New Zealand Limited

INN (International Name):

Lincomycin hydrochloride monohydrate 340.26 mg/mL (= lincomycin 300 mg/mL)

복용량:

300 mg/mL

약제 형태:

Solution for injection

구성:

Active: Lincomycin hydrochloride monohydrate 340.26 mg/mL equivalent to lincomycin 300 mg/mL Excipient: Benzyl alcohol Water for injection

패키지 단위:

Vial, glass, Type I flint glass, West 1888 gray butyl rubber stopper, metal overseal, plastic flip-off cap; 5x2mL, 10 mL

수업:

Prescription

처방전 유형:

Prescription

Manufactured by:

Pharmacia & Upjohn Company LLC

제품 요약:

Package - Contents - Shelf Life: Vial, glass, Type I flint glass, West 1888 gray butyl rubber stopper, metal overseal, plastic flip-off cap; 5x2mL - 10 mL - 24 months from date of manufacture stored at or below 25°C

승인 날짜:

2011-01-05

환자 정보 전단

 
LINCOCIN


LINCOMYCIN HYDROCHLORIDE 
CONSUMER MEDICINE INFORMATION 

WHAT IS IN THIS LEAFLET 
Please read this leaflet carefully 
before you start using LINCOCIN 
injection.  This leaflet answers 
some common questions about 
LINCOCIN injection.  It does not 
contain all the available 
information.  It does not take the 
place of talking to your doctor or 
pharmacist. 
All medicines have risks and 
benefits.  Your doctor has weighed 
the risks of you using LINCOCIN 
against the benefits it is expected to 
have for you.  Use LINCOCIN as 
instructed and follow the advice 
given in this leaflet. 
IF YOU HAVE ANY CONCERNS ABOUT 
TAKING THIS MEDICINE, ASK YOUR 
DOCTOR OR PHARMACIST. 
Keep this leaflet with your 
medicine.  You may need to read it 
again. 
WHAT LINCOCIN IS 
USED FOR 
LINCOCIN is an antibiotic used to 
treat serious infections in different 
parts of the body caused by certain 
bacteria.  LINCOCIN works by 
killing or stopping the growth of 
bacteria causing your infection. 
The specific infections for which 
LINCOCIN is used include:  ear, 
throat and lung infections; skin 
infections; bone and joint 
infections; and infections of the 
blood. 
LINCOCIN will not work against 
viral infections such as colds or flu. 
Your doctor may have prescribed 
LINCOCIN for another reason. 
Ask your doctor if you have any 
questions about why LINCOCIN 
has been prescribed for you. 
This medicine is available only with 
a doctor's prescription. 
LINCOCIN is not addictive. 
BEFORE YOU USE 
LINCOCIN 
Some information is provided 
below.  However, always talk to 
your doctor if you have concerns or 
questions about your treatment. 
WHEN YOU MUST NOT USE 
LINCOCIN 
DO NOT USE LINCOCIN IF: 
1.  YOU HAVE AN ALLERGY TO: 
  CLINDAMYCIN OR 
LINCOMYCIN 
  ANY OF THE OTHER 
INGREDIENTS LISTED AT THE 
END OF THIS LEAFLET  
(see 'Product Description') 
Symptoms of an allergic 
reaction may

제품 특성 요약

 
Version: pfdlinci11210 
MoH Approved: 

Commercial/Non-Commercial 
Page 1 of 9 
DATA SHEET 

LINCOCIN
®

LINCOMYCIN INJECTION 
DESCRIPTION 
Non-proprietary name:  lincomycin hydrochloride 
Chemical Name: Lincomycin hydrochloride consists mainly of the
monohydrate of methyl 
6,8-dideoxy-6-[(_2S,4R_)-1-methyl-4-propylpyrrolidine-2-carboxamido]-1-thio-
D
-erythro-
-
D
-
galacto-octopyranoside hydrochloride. 
CAS Number: 7179-49-9 
The structure of lincomycin hydrochloride is: 

ACTIONS 
LINCOCIN (lincomycin hydrochloride) is the monohydrated salt of
lincomycin, a substance 
produced by the growth of a member of the lincolnensis group
of _Streptomyces lincolnensis _
_(fam. Streptomycetaceae)_.  It is a white, or practically white,
crystalline powder and is 
odourless or has a faint odour.  Its solutions are acid and are
dextrorotatory.  LINCOCIN is 
freely soluble in water, soluble in dimethylformamide and very
slightly soluble in acetone. 
LINCOCIN Injection is a clear, colourless or almost colourless
solution, practically free from 
particles. 
MICROBIOLOGY 
_In vitro_ studies indicate that the following organisms are usually
sensitive to concentrations 
achieved normally in the serum following recommended
doses:  _Staphylococcus aureus, _
_Staphylococcus epidermidis_, beta-haemolytic
Streptococcus, _Streptococcus viridans, _
_Streptococcus pneumoniae, Clostridium tetani, Clostridium
perfringens, Corynebacterium _
_diphtheriae._ 

Version: pfdlinci11210 
MoH Approved: 

Commercial/Non-Commercial 
Page 2 of 9 
NOTE: 
The drug is not active against most strains of _Enterococcus
faecalis_, nor against _Neisseria _
_gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae_ or
other gram-negative 
organisms or yeasts.  Some strains of _Clostridium
perfringens_ and strains of some less 
common human pathogens of Clostridia may be lincomycin-resistant.
 Depending on the 
sensitivity of the organism and concentration of the antibiot